OQROStart free trial
Politician trade (House)

Johnson & Johnson (JNJ): Rep. Jefferson Shreve (IN06) disclosed a sale $50K–$100K

Rep. Jefferson Shreve (IN06) disclosed a sale of Johnson & Johnson in the $50K–$100K range.

$50,001–$100,000
Reported range · official band, not an exact amount
41 days
Disclosure lag
Traded
May 12, 2025
Disclosed
Jun 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Sep 26, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  3. Mar 3, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  4. Mar 4, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Mar 5, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  6. Mar 7, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  7. Mar 24, 2025CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  8. Mar 31, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  9. Apr 1, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  10. Apr 8, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  11. Apr 9, 2025CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
  12. Apr 21, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  13. Apr 22, 2025FDARecall: Endopath Echelon Vascular White Reload for Advanced Placement Tip (35mm, 4 row); Product code VASECR35
  14. Apr 24, 2025FDAFDA device clearance: MENTOR™ PliaForm™ Breast Tissue Expander w/ Suture Tabs
  15. Apr 29, 2025FDAFDA drug approval: Imaavy
  16. Apr 29, 2025Congress · 1 personMembers of Congress: 2 sales
  17. May 2, 2025FDAFDA device clearance: Shockwave CS Guide Catheter
  18. May 5, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  19. May 12, 2025 · this disclosureCongressDisclosed sale of JNJ — reported range $50,001 - $100,000

What came next

  1. May 14, 2025FDAFDA device clearance: ETHICON 4000 60mm Compact Stapler (EC3D60C); ETHICON 4000 60mm Standard Stapler (EC3D60S); ETHICON 4000 60mm Long Stapler (EC3D60L); ETHICON 3D 60mm White Relo…
  2. May 23, 2025FDAFDA device clearance: RECLAIM Monobloc Revision Femoral Stem
  3. May 30, 2025CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
  4. Jun 10, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Jun 12, 2025FDARecall: ACUVUE¿ OASYS MAX 1-Day MULTIFOCAL
  6. Jun 12, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  7. Jun 16, 2025CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
  8. Jun 17, 2025CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  9. Jun 23, 2025FDARecall: Automated Impella Controller (AIC), used in left heart support blood pump, including the following: 1. Impella Controller, Packaged, AU; Product Code: 0042-000…
  10. Jun 24, 2025CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  11. Jul 17, 2025InsiderOfficer sold ~$3.13M of JNJ shares in the open market
  12. Jul 28, 2025FDAFDA drug approval: Sirturo
  13. Jul 31, 2025CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  14. Aug 14, 2025FDAFDA drug approval: Rybrevant
  15. Aug 14, 2025FDAFDA drug approval: Lazcluze
  16. Aug 15, 2025FDARecall: STRATAFIX Spiral PDS Plus Bidirectional Knotless Tissue Control Device, SFX SPI PDS+ BI VIO 14X14IN(36X36CM) USP1(M4) D/A MO-4. Product Code: SXPP2B400-11.
  17. Aug 15, 2025InsiderCFO sold ~$2.98M of JNJ shares in the open market
  18. Aug 20, 2025FDARecall: Automated Impella Controller (AIC) with the below brands and product codes. Used with heart assist pump. 1. Impella Controller, Packaged, US; Product Code: 004…
  19. Aug 22, 2025FDAFDA device clearance: CARTO™ 3 EP Navigation System V8.1
  20. Aug 22, 2025InsiderCEO sold ~$22.5M of JNJ shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Jefferson Shreve (IN06)

The full history of Rep. Jefferson Shreve (IN06) is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data